dangers of glp 1 drugs GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Best Practices for Managing Common

In 2009, a second GLP-1 RA was approved liraglutide, which has to be injected once daily

Frederick et al., 2016), reduces the mitochondrial unfolded protein response (Mendelsohn and Larrick, 2017), disrupts ATP biosynthesis, decreases the ability to pump calcium against the intracellular gradient (Camandola and Mattson, 2011), disrupts calcium homeostasis, increases excitotoxicity (Rzheshevsky, 2014) and has deleterious effects on muscle health (Goody and Henry, 2018)

Anti-aggression effects documented at the same 0.5 mg/kg dose showed a 5-fold reduction in physical attacks within aggressive environments, occurring within 12 minutes of administration

Sisodiya, S

Cell 179:312339